Oncology & Cancer

Study finds cancer patients do benefit from COVID-19 vaccination

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...

Vaccination

Pfizer booster more than 50% protective against omicron

A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against ...

Vaccination

mRNA-1273 SARS-CoV-2 vaccine seems safe for adolescents

(HealthDay)—The results of an interim analysis suggest that two doses of the Moderna mRNA-1273 vaccine safely induce protective levels of antibodies to SARS-CoV-2 among adolescents, according to a study published online ...

Vaccination

Breakthrough SARS-CoV-2 infections ID'd in fully vaccinated

(HealthDay)—Breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among fully vaccinated health care workers are mainly mild or asymptomatic, according to a study published online July 28 ...

Diseases, Conditions, Syndromes

New study provides data on protections of Ebola vaccines

A new study published in Science Translational Medicine reports on the Ebola vaccine-mediated protection of five mucosal vaccine vectors based on the human and avian paramyxoviruses. The study comprehensively characterized ...

page 1 from 2